ClinicalTrials.gg
Drug

Avexitide clinical trials

Also written Exendin (9-39).

Includes 1 study of Avexitide acetate.

studies test it
36
open now
6
in phase 3
4
first study started
1999

How each study uses avexitide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the avexitide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Exendin 9-39
11
Exendin-9,39
6
Exendin-(9-39)
6
Avexitide
3
no other name for Exendin-(9-39)
3

Other names

Exendin (9-39)
8
exendin(9-39)amide
3

Studies by the year they started

36 studies that test it; most in 2014 (5)

Studies that test avexitide, by start year
YearStudies
19991
20041
20051
20071
20093
20102
20111
20132
20145
20153
20163
20172
20182
20213
20221
20252
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
11
Phase 2
10
Phase 3
4
Phase 4
2
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 34

Mayo Clinic (7) · Diva De Leon (4) · Adrian Vella (3) · Tracey McLaughlin (3) · The University of Texas Health Science Center at San Antonio (3) · University Hospital, Gentofte, Copenhagen (2) · Ludwig-Maximilians - University of Munich (2) · Amylyx Pharmaceuticals Inc. (1)

Often tested with

Tested in the same studies.

Atropine (3) · Glucagon-Like Peptide 1 (2) · Liraglutide (1) · Acarbose (1) · Metformin (1) · Pegvisomant (1) · Omega-N-Methylarginine (1) · Sitagliptin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test avexitide.

Studies

Open first, then newest update. How each study uses avexitide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 36

See all 36 studies that test avexitide →

Given beside what is tested · 2 — avexitide is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with avexitide

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call avexitide · ClinicalTrials.gg INT003753

  • MeSH (NLM) C083773exendin (9-39)Confirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 5313W10MYTAVEXITIDEConfirmed FDA, NLM
  • NCI Thesaurus C133230AvexitideOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.